The Current Ratio as of December 2025 (TTM) for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) is 18.85

According to TaiwanJ Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 18.85. This represents a change of 33.34% compared to the average of 14.13 of the last 4 quarters.

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Historical Current Ratio (quarterly & annually)

How has 6549.TWO Current Ratio performed in the past?

The mean historical Current Ratio of TaiwanJ Pharmaceuticals Co., Ltd. over the last ten years is 10.98. The current 18.85 Current Ratio has changed 17.07% with respect to the historical average. Over the past ten years (40 quarters), 6549.TWO's Current Ratio was at its highest in in the June 2023 quarter at 22.05. The Current Ratio was at its lowest in in the June 2019 quarter at 0.

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of TaiwanJ Pharmaceuticals Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Average Current Ratio

How has 6549.TWO Current Ratio performed in the past?

The current Current Ratio of TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) Current Ratio vs. Peers

How is 6549.TWO’s Current Ratio compared to its peers?

TaiwanJ Pharmaceuticals Co., Ltd.’s Current Ratio is greater than Vectorite Biomedical Inc. (13.46), greater than Health & Life Co., Ltd. (3.27), greater than BioLASCO Taiwan Co., Ltd. (2.48), greater than Original BioMedicals Co., Ltd. (13.55), less than Eusol Biotech Co.,Ltd. (43.56), greater than Bioray Biotech Co., Ltd (7.15), greater than SynCore Biotechnology Co.,Ltd (11.18), greater than Pharmigene, Inc. (2.46), greater than Sofiva Genomics Co.,Ltd. (2.90), greater than Andros Pharmaceuticals Co.,Ltd (13.81),

Build a custom stock screener for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiwanJ Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TaiwanJ Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.